Takeda Wins Attorneys Fees In Patent Suit
A federal judge ruled on Wednesday that two generic drug companies that infringed on Takeda's patent for a diabetes treatment must pay its attorneys fees as well....To view the full article, register now.
Already a subscriber? Click here to view full article